Reply to: “ARID3A variant and the risk of primary biliary cholangitis in a Central European cohort”

We thank Dr. Krawczyk and his colleagues for the interest in our work and for the efforts to validate the role of AT-rich interaction domain 3A (ARID3A) in primary biliary cholangitis (PBC) using a large Central European cohort.1

Source: Journal of Hepatology - January 30, 2024 Category: Gastroenterology Authors: Ruqi Tang, You Li, Ruiling Chen, Xiong Ma Tags: Letter to the Editor Source Type: research